FITC Anti-IL-6R antibody [B-R6]
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal IL-6R antibody - conjugated to FITC. Suitable for Flow Cyt and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Cell preparation containing IL6R protein.
View Alternative Names
CD126, Interleukin-6 receptor subunit alpha, IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA, IL-6R 1, Membrane glycoprotein 80, gp80, IL6R
- Flow Cyt
Unknown
Flow Cytometry - FITC Anti-IL-6R antibody [B-R6] (AB27321)
ab27321 at 10μl/106 cells staining IL6R in U266 cell line by Flow Cytometry.
This image was generated using the ascites version of the product.
Related conjugates and formulations (1)
-
Anti-IL-6R antibody [B-R6]-BSA and Azide free
Reactivity data
Product details
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-6 receptor function involves mediating the effects of IL-6 through its interaction with glycoprotein 130 (gp130) forming a signaling complex. This complex initiates intracellular pathways that lead to gene expression changes necessary for immune responses inflammation and hematopoiesis. When IL-6 binds IL-6R the complex formation with gp130 triggers downstream signaling that impacts cell growth differentiation and survival.
Pathways
IL-6R is central to the JAK/STAT signaling pathway one of the two main pathways activated by IL-6 signaling. It's also involved in the MAPK cascade contributing to cellular responses such as proliferation and differentiation. Through these pathways IL-6R interacts with other proteins like JAK kinases and STAT transcription factors coordinating cellular responses to external signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 20:339 PubMed33123250
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:263 PubMed32989397
2020
Applications
Unspecified application
Species
Unspecified reactive species
Leukemia & lymphoma 59:178-186 PubMed28540748
2017
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells (Dayton, Ohio) 27:2393-404 PubMed19658188
2009
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com